Bernard P - Search Results

1

Pyrazolo[1,5-a]-1,3,5-triazine as a purine bioisostere: access to potent cyclin-dependent kinase inhibitor (R)-roscovitine analogue.

Popowycz F, Fournet G, Schneider C, Bettayeb K, Ferandin Y, Lamigeon C, Tirado OM, Mateo-Lozano S, Notario V, Colas P, Bernard P, Meijer L, Joseph B. Popowycz F, et al. Among authors: bernard p. J Med Chem. 2009 Feb 12;52(3):655-63. doi: 10.1021/jm801340z. J Med Chem. 2009. PMID: 19128055 Free PMC article.

2

Cyclic nucleotide phosphodiesterase type 4 inhibitors: evaluation of pyrazolo[1,5-a]-1,3,5-triazine ring system as an adenine bioisostere.

Raboisson P, Schultz D, Muller C, Reimund JM, Pinna G, Mathieu R, Bernard P, Do QT, Desjarlais RL, Justiano H, Lugnier C, Bourguignon JJ. Raboisson P, et al. Among authors: bernard p. Eur J Med Chem. 2008 Apr;43(4):816-29. doi: 10.1016/j.ejmech.2007.05.016. Epub 2007 Jun 8. Eur J Med Chem. 2008. PMID: 17640774

3

N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine.

Bettayeb K, Sallam H, Ferandin Y, Popowycz F, Fournet G, Hassan M, Echalier A, Bernard P, Endicott J, Joseph B, Meijer L. Bettayeb K, et al. Among authors: bernard p. Mol Cancer Ther. 2008 Sep;7(9):2713-24. doi: 10.1158/1535-7163.MCT-08-0080. Mol Cancer Ther. 2008. PMID: 18790752 Free article.

4

Indolobenzazepin-7-ones and 6-, 8-, and 9-membered ring derivatives as tubulin polymerization inhibitors: synthesis and structure--activity relationship studies.

Putey A, Popowycz F, Do QT, Bernard P, Talapatra SK, Kozielski F, Galmarini CM, Joseph B. Putey A, et al. Among authors: bernard p. J Med Chem. 2009 Oct 8;52(19):5916-25. doi: 10.1021/jm900476c. J Med Chem. 2009. PMID: 19743863

5

New imidazo[1,2-b]pyrazoles as anticancer agents: synthesis, biological evaluation and structure activity relationship analysis.

Grosse S, Mathieu V, Pillard C, Massip S, Marchivie M, Jarry C, Bernard P, Kiss R, Guillaumet G. Grosse S, et al. Among authors: bernard p. Eur J Med Chem. 2014 Sep 12;84:718-30. doi: 10.1016/j.ejmech.2014.07.057. Epub 2014 Jul 18. Eur J Med Chem. 2014. PMID: 25064349

6

Molecular modeling of the GABA/GABA(B) receptor complex.

Bernard P, Guedin D, Hibert M. Bernard P, et al. J Med Chem. 2001 Jan 4;44(1):27-35. doi: 10.1021/jm000915o. J Med Chem. 2001. PMID: 11141085

7

Optimization and validation of a docking-scoring protocol; application to virtual screening for COX-2 inhibitors.

Mozziconacci JC, Arnoult E, Bernard P, Do QT, Marot C, Morin-Allory L. Mozziconacci JC, et al. Among authors: bernard p. J Med Chem. 2005 Feb 24;48(4):1055-68. doi: 10.1021/jm049332v. J Med Chem. 2005. PMID: 15715473

8

Application of drug repositioning strategy to TOFISOPAM.

Bernard P, Dufresne-Favetta C, Favetta P, Do QT, Himbert F, Zubrzycki S, Scior T, Lugnier C. Bernard P, et al. Curr Med Chem. 2008;15(30):3196-203. doi: 10.2174/092986708786848488. Curr Med Chem. 2008. PMID: 19075663

9

A molecular modeling and 3D QSAR study of a large series of indole inhibitors of human non-pancreatic secretory phospholipase A2.

Bernard P, Pintore M, Berthon JY, Chrétien JR. Bernard P, et al. Eur J Med Chem. 2001 Jan;36(1):1-19. doi: 10.1016/s0223-5234(00)01183-1. Eur J Med Chem. 2001. PMID: 11231045

10

Efficient synthesis and first regioselective C-3 direct arylation of imidazo[1,2-b]pyrazoles.

Grosse S, Pillard C, Massip S, Léger JM, Jarry C, Bourg S, Bernard P, Guillaumet G. Grosse S, et al. Among authors: bernard p. Chemistry. 2012 Nov 19;18(47):14943-7. doi: 10.1002/chem.201202593. Epub 2012 Oct 19. Chemistry. 2012. PMID: 23086664

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,887 results

Search Page

Filters